3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 24496001 | RANKL inhibition blocks osteolytic lesions and reduces skeletal tumor burden in models of non-small-cell lung cancer bone metastases. | 2014 Mar | 1 |
2 | 18792431 | Re: RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastasis model. | 2008 Sep | 1 |
3 | 16651437 | Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. | 2006 May 1 | 2 |